ArticleDrug safety2019

Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.

Valeria Belleudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.